智能药物代码交付平台用于免疫微环境重建和骨髓瘤治疗中的免疫化疗
Yi Zhang1, Yuxuan Wu1, Yuanzhuo Xie1
1Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing 210008, PR China.
概括
这项研究引入了一种用于骨髓瘤治疗的新型纳米平台 (HANPDOX),结合化疗药物,通过激活免疫反应和抑制瘤生长和转移来增强免疫疗法的有效性.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 免疫抑制性瘤微环境 (TME) 限制了在骨髓瘤中免疫治疗的有效性.
- 诱导免疫细胞死亡 (ICD) 的化疗可以激活抗瘤免疫反应.
- 将化疗与免疫疗法结合起来,为骨髓瘤治疗提供了一个有前途的策略.
研究的目的:
- 设计一个纳米尺寸的平台 (HANPDOX) 共同提供多克索鲁比辛 (DOX) 和西斯 (CDDP).
- 为了研究这个平台与抗编程细胞死亡-1 (aPD-1) 治疗相结合的协同抗瘤效应.
- 评估这种组合作为骨髓瘤免疫化学疗法的潜力.
主要方法:
- 开发一个双药载纳米平台 (CCHANPDOX) 针对性交付.
- 对DOX诱导的免疫细胞死亡 (ICD) 和TME调节的评估.
- 在体内对抗瘤疗效的评估,包括瘤生长抑制,复发和转移抑制,与aPD-1疗法结合.
主要成果:
- CCHANPDOX平台成功地同时提供了DOX和CDDP,诱导了ICD并增强了TME免疫性.
- 与CC和HANPDOX和aPD-1的联合治疗显著抑制了瘤生长,复发和肺转移.
- 增强的抗瘤效应归因于强大的免疫反应和建立的免疫记忆.
结论:
- 该CCHANPDOX纳米平台有效地重建了TME的免疫性,使骨髓瘤对aPD-1免疫疗法的敏感.
- 这种组合策略显示出抑制瘤进展和转移的巨大潜力.
- 开发的免疫化学疗法充满希望,作为骨髓瘤的新疗法选择.
更多相关视频
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.3K
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
9.9K
相关概念视频
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
